weight regain after tirzepatide withdrawal leads to 25% in 82.5% of adults Rebound Weight Gain After Stopping

But truly the best purchase Ive made

Higher doses (7.5 mg and 15 mg) are associated with higher nausea rates in clinical trials, but individual responses vary widely based on genetics, stomach sensitivity, and food timing

Gastrointestinal adverse effects (nausea, vomiting, diarrhoea) occur at similar frequencies to other GLP-1 receptor agonists, affecting approximately 12% to 24% of patients (nausea being most common), and are typically more frequent during dose escalation

Mounjaro isnt approved for use in people with type 1 diabetes

In conclusion, when used alongside a lifestyle intervention program, pramlintide treatment with specific dosing regimens helped obese individuals achieve greater initial weight loss and improved long-term maintenance of weight loss

Small errors in syringe handling translate directly into dosing errors that affect your results and side effect profile